Business Context and Reporting Period
Company: Constellation Brands, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 14, 2018
Event: Entry into a Material Definitive Agreement to significantly increase its investment in Canopy Growth Corporation ("Canopy").
Key Financial Metrics and Transaction Details
- Transaction Value: C$5.1 billion purchase price for 104,500,000 Canopy common shares.
- Ownership Stake: Post-transaction, Constellation will own approximately 38% of Canopy's outstanding common shares on a consolidated basis. Upon full exercise of warrants, ownership would reach approximately 55% on a fully diluted basis.
- Warrants: Constellation acquired warrants to purchase an additional 139,745,453 Canopy shares (88.5 million immediately exercisable; 51.3 million exercisable upon full exercise of the first tranche).
- Financing Structure:
- Bridge Loan: C$5.0787 billion senior unsecured 364-day term loan facility committed by Bank of America, N.A.
- Term Facilities: Commitments for a new three-year term loan (up to $500 million) and a five-year term loan (up to $1 billion).
- Revolving Facilities: Increase in commitments from $1.5 billion to $2.0 billion.
- Financial Covenants (Post-Closing): Minimum interest coverage ratio of 2.50 to 1.00; maximum total net leverage ratio of 5.25 to 1.00.
Material Changes and Strategic Shifts
This filing represents a material expansion of Constellation's existing 8.5% stake in Canopy. Key changes include:
- Board Control: The Canopy Board will expand from five to seven directors, with Constellation entitled to designate four nominees.
- Exclusivity: Constellation has agreed that Canopy will be its exclusive strategic vehicle for cannabis products globally.
- Non-Compete: Constellation is subject to non-competition restrictions regarding cannabis opportunities for a limited period.
- Shareholder Approval: The transaction is subject to Canopy shareholder approval, scheduled for a special meeting on September 26, 2018.
Outlook, Risks, and Contingencies
- Closing Timeline: The transaction is projected to be consummated in the fourth calendar quarter of 2018.
- Termination Fees: Canopy must pay a termination fee to Constellation if the agreement is terminated under specific "Termination Fee Events," such as the Canopy Board withdrawing its recommendation or accepting a superior proposal.
- Regulatory Risks: Closing is contingent on regulatory approvals under the Investment Canada Act and Competition Act, as well as stock exchange approvals.
- Financing Risks: The bridge loan commitment expires on April 1, 2019, or upon termination of the purchase agreement. The loan is subject to solvency certifications and customary closing conditions.
- Legal Risks: An event of default includes the seizure of property under the Controlled Substances Act, reflecting the regulatory environment of the cannabis industry.
Investor Verification Checklist
- Verify the final closing date and confirmation of regulatory approvals (Investment Canada Act, Competition Act).
- Monitor the Canopy shareholder vote scheduled for September 26, 2018, to ensure the transaction is approved.
- Review the final terms of the permanent debt financing (Term and Revolving Facilities) to confirm the replacement of the bridge loan.
- Assess the impact of the new debt load on Constellation's credit rating and ability to meet the 5.25:1 leverage covenant.
- Confirm the appointment of the four Constellation-nominated directors to the Canopy Board.